Evidence map›Paper›PMID 37521855›Full record

ArticleActa pharmaceutica Sinica. B2023

Oral nano-formulation improves pancreatic islets dysfunction

Lin Hou, Xueyuan Peng, Ruiting Wang, Yifei Wang, Hong Li, Huijuan Zhang, Yun Zhang, Zhenzhong Zhang

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lin HouSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Xueyuan PengSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Ruiting WangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Yifei WangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Hong LiSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Huijuan ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Yun ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Zhenzhong ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) therapy is facing the challenges of long-term medication and gradual destruction of pancreatic islet

Indexed as

HydroxychloroquineLymphatic transportationOral drug deliveryPancreas microenvironmentPancreatic islet β-cellsPLGA nanoparticlesTaurocholic acidType 2 diabetes mellitus

Identifiers

PMID37521855
PMCPMC10373096
OpenAlexW4312193618

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.